NASDAQ: CSBR - Champions Oncology, Inc.

Доходность за полгода: -8.84%
Сектор: Healthcare

График акции Champions Oncology, Inc.


О компании

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

Подробнее
In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Выручка 0.0271
EBITDA 0.000876
Число акций ао 0.01354 млрд
P/E 1001.04
P/S 4.73
P/BV 57.25
EV/EBITDA 142.59
Цена ао 5.02
ISIN US15870P3073
Сайт https://www.championsoncology.com
Валюта usd
IPO date 2003-01-10
Sector Health Care
Industry Life Sciences Tools & Services
Валюта отчета usd
Изменение цены за день: +0.6652% (4.51)
Изменение цены за неделю: -5.61% (4.81)
Изменение цены за месяц: +8.51% (4.184)
Изменение цены за 3 месяца: -10.1% (5.05)
Изменение цены за полгода: -8.84% (4.98)
Изменение цены за год: -26.77% (6.2)
Изменение цены за 3 года: -56.76% (10.5)
Изменение цены за 5 лет: -20.77% (5.73)
Изменение цены с начала года: -9.38% (5.01)

Недооценка

Название Значение Оценка
P/S 1.27 9
P/BV 14.78 1
P/E 197.15 1
EV/EBITDA -48 0
Итого: 3.25

Эффективность

Название Значение Оценка
ROA, % -15.55 0
ROE, % -115.08 0
Итого: 0

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого: 0

Долг

Название Значение Оценка
Debt/EBITDA -6.16 10
Итого: 9.4

Импульс роста

Название Значение Оценка
Доходность Revenue, % 56.25 7
Доходность Ebitda, % 1540.91 10
Доходность EPS, % 221.98 10
Итого: 7.4

Институционалы Объем Доля, %
Battery Management Corp. 2421673 17.81
NEA Management Company, LLC 1713720 12.61
Tocqueville Asset Management L.P. 684578 5.04
Renaissance Technologies, LLC 124791 0.92
Blackrock Inc. 116097 0.85
Vanguard Group Inc 82837 0.61
Essex Investment Management Co LLC 77200 0.57
Ameriprise Financial, Inc. 75044 0.55
Geode Capital Management, LLC 61349 0.45
Northern Trust Corporation 44917 0.33

ETF Доля, % Доходность за год, % Дивиденды, %
iShares Micro-Cap ETF 0.00839 35.054312164247 1.54048



Руководитель Должность Оплата Год рождения
Dr. Ronnie Morris M.D. CEO & Director 600k 1966 (58 лет)
Mr. David Barry Miller M.B.A. Chief Financial Officer 285k 1969 (55 лет)
Mr. Brady Davis President N/A 1969 (55 лет)
Dr. Maria Mancini Ph.D. Chief Operating Officer N/A
Mr. Arthur Hanson Vice President of Technology N/A
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS Vice President of Global Marketing N/A
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG Executive Vice President of Global Laboratory Operations N/A
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer N/A
Dr. Karin Abarca Heidemann Ph.D. Executive Vice President of Global Scientific Operations N/A
Dr. Marianna Zipeto Ph.D. Executive Vice President of Commercial, Research Services & Partnering N/A

Адрес: United States, Hackensack. NJ, One University Plaza - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.championsoncology.com